lncRNA在食管癌中的作用机制研究进展

doi:10.3760/cma.j.cn441417-20250410-20010

摘要/Abstract

摘要：

食管癌是消化系统里高发且危险的恶性肿瘤之一，在亚洲地区更为常见。它的发病是受多种因素影响、历经多个阶段、涉及多个基因参与的复杂病理过程，环境因素、生活习惯、慢性炎症、遗传易感性以及分子机制等共同参与其中。近年，长链非编码RNA（long non-coding RNA，lncRNA）作为关键调控因子在食管癌中发挥的作用备受瞩目。lncRNA是一类长度超过200个核苷酸的非编码RNA，其调控基因表达的方式多样，涵盖表观遗传修饰、竞争性内源RNA网络、RNA-蛋白相互作用等机制。研究发现，在食管癌中，lncRNA参与调控肿瘤细胞诸多关键生物学过程，如增殖、侵袭、转移、凋亡、耐药性、放射抗性、干细胞特性以及上皮-间质转化（epithelial-mesenchymal transition，EMT）等。本综述全面梳理了lncRNA在食管癌病理生理学中的广泛调控作用及潜在的临床价值，着重阐述了其参与的调控轴在食管癌中的具体作用，为未来深入探究lncRNA的分子机制和临床转化应用提供方向，也为改善食管癌患者预后、探寻治疗靶点提供新的思路。

关键词:

食管癌, 长链非编码RNA, 机制, 进展

Abstract:

Esophageal cancer is one of the common and dangerous malignant tumors in the digestive system, particularly in Asia. Its onset is a complex pathological process through multiple stages influenced by multiple factors and genes. Environmental factors, living habits, chronic inflammation, genetic susceptibility, and molecular mechanisms are all involved. In recent years, the roles of long non-coding RNA (lncRNA) as a key regulatory factor in esophageal cancer have attracted much attention. LncRNA is a type of non-coding RNA with a length exceeding 200 nucleotides. It regulates gene expression in various ways, including epigenetic modifications, competitive endogenous RNA networks, RNA protein interactions, and other mechanisms. Researches have found that in esophageal cancer, lncRNAs are involved in regulating many key biological processes of tumor cells, such as proliferation, invasion, metastasis, apoptosis, drug resistance, radiation resistance, stem cell characteristics, epithelial mesenchymal transition (EMT), etc. This review comprehensively summarizes the extensive regulatory roles and potential clinical value of lncRNA in the pathophysiology of esophageal cancer, with a focus on the specific role of the regulatory axis which participates in esophageal cancer, so as to provide directions for the further exploration of the molecular mechanisms and clinical translational applications of lncRNA in the future, as well as new ideas for improving the prognosis of patients with esophageal cancer and exploring therapeutic targets.

Key words:

Esophageal cancer, Long non-coding RNA, Mechanism, Progress

林宇宁谢鸿燕赵文镇张忠英金宏伟.

lncRNA在食管癌中的作用机制研究进展 [J]. 国际医药卫生导报, 2025, 31(20): 3389-3395.

Lin Yuning, Xie Hongyan, Zhao Wenzhen, Zhang Zhongying, Jin Hongwei.

Research progress on mechanism of roles of lncRNA in esophageal cancer [J]. International Medicine and Health Guidance News, 2025, 31(20): 3389-3395.

参考文献

[1] Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3):229-263. DOI: 10.3322/caac.21834.
[2] Teng Y, Xia C, Cao M, et al. Esophageal cancer global burden profiles, trends, and contributors[J]. Cancer Biol Med, 2024, 21(8):656–666. DOI: 10.20892/j.issn.2095-3941.2024.0145.
[3] Yokoyama A, Kakiuchi N, Yoshizato T, et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers[J]. Nature, 2019, 565(7739):312-317. DOI: 10.1038/s41586-018-0811-x.
[4] Zhuang P, Wu F, Liu X, et al. Preserved vegetable consumption and its association with mortality among 440,415 people in the China Kadoorie Biobank[J]. BMC Med, 2023, 21(1):135. DOI: 10.1186/s12916-023-02829-3.
[5] 张嫣然,宇传华,胡迪,等. 1990-2019年中国归因于水果摄入不足的食管癌死亡趋势[J]. 中华疾病控制杂志,2023,27(1):4-10. DOI:10.16462/j.cnki.zhjbkz.2023.01.002.
[6] Wong MCS, Deng Y, Huang J, et al. Performance of screening tests for esophageal squamous cell carcinoma: a systematic review and meta-analysis[J]. Gastrointest Endosc, 2022, 96(2):197-207.e34. DOI: 10.1016/j.gie.2022.04.005.
[7] Min Q, Zhang M, Lin D, et al. Genomic characterization and risk stratification of esophageal squamous dysplasia [J]. Med Rev (2021), 2024, 4(3): 244-256. DOI: 10.1515/mr-2024-0008.
[8] Vassilenko V, Moura PC, Raposo M. Diagnosis of carcinogenic pathologies through breath biomarkers: present and future trends[J]. Biomedicines, 2023, 11(11): 3029. DOI: 10.3390/biomedicines11113029.
[9] 冯绪梅,宋相庆,季冠虹,等. 血浆外泌体miR-548k在食管鳞癌中的表达及诊断价值[J]. 山东大学学报(医学版),2024,62(5):79-88. DOI: 10.6040/j.issn.1671-7554.0.2024.0134.
[10] Wang X, Yu N, Cheng G, et al. Prognostic value of circulating tumour DNA during post-radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma[J]. Clin Transl Med, 2022,12(11): e1116. DOI: 10.1002/ctm2.1116.
[11] 赵文镇,林宇宁. LINC01836是一种新的结直肠癌诊断和预后的生物标志物[J]. 国际医药卫生导报,2022,28(3):363-367. DOI: 10.3760/cma.j.issn.1007-1245.2022.03.017.
[12] 蔡灿锋,李锦宏,辛海洋,等. 直肠癌新辅助放化疗疗效lncRNA分子预测模型构建[J]. 国际医药卫生导报,2024,30(19):3170-3175. DOI:10.3760/cma.j.issn.1007-1245.2024.19.001.
[13] Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function[J]. J Cell Biol, 2021, 220(2):e202009045. DOI: 10.1083/jcb.202009045.
[14] Fu H, Wang T, Kong X, et al. A nodal enhanced micropeptide NEMEP regulates glucose uptake during mesendoderm differentiation of embryonic stem cells[J]. Nat Commun, 2022,13(1):3984. DOI: 10.1038/s41467-022-31762-x.
[15] Jia J, Li H, Chu J, et al. LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis[J]. J Cancer, 2021, 12(4):1200-1211. DOI: 10.7150/jca.54007.
[16] Han B, Ma Y, Yang P, et al. Novel histone acetylation-related lncRNA signature for predicting prognosis and tumor microenvironment in esophageal carcinoma[J]. Aging (Albany NY), 2024, 16(6):5163-5183. DOI: 10.18632/aging.205636.
[17] Chen MJ, Deng J, Chen C, et al. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis[J]. Int J Biochem Cell Biol, 2019, 113:27-36. DOI: 10.1016/j.biocel.2019.05.011.
[18] 秦玉萍,曹通,许颖,等.敲低lncRNA CACNA1C-AS2促进上皮间质转化增强人食管癌细胞的增殖、侵袭和迁移[J].细胞与分子免疫学杂志,2023,39(3):249-257.
[19] Xu J, Liu X, Liu X, et al. noncoding RNA KCNMB2-AS1 promotes the development of esophageal cancer by modulating the miR-3194-3p/PYGL axis[J]. Bioengineered, 2021, 12(1):6687-6702. DOI: 10.1080/21655979.2021.1973775.
[20] Wang J, Zhang Z, Song L, et al. Inhibition of esophageal squamous cell carcinoma progression by MIR210HG and activation of the P53 signaling pathway to promote apoptosis and autophagy[J]. Eur J Med Res, 2025, 30(1):269. DOI: 10.1186/s40001-025-02512-8.
[21] Tuersong T, Shataer M, Chen Y, et al. Extracellular vesicle-lncRNA HOTAIR modulates esophageal cancer chemoresistance and immune microenvironment via miR-375/CDH2 pathway[J]. J Cell Commun Signal, 2025, 19(2): e70014. DOI: 10.1002/ccs3.70014.
[22] Plath K, Fang J, Mlynarczyk-Evans SK, et al. Role of histone H3 lysine 27 methylation in X inactivation[J]. Science, 2003, 300(5616):131-135. DOI: 10.1126/science.1084274.
[23] Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals[J]. Nature, 2009,458(7235):223-227. DOI: 10.1038/nature07672.
[24] Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs[J]. Cell, 2007, 129(7):1311-1323. DOI: 10.1016/j.cell.2007.05.022.
[25] Rinn JL, Chang HY. Genome regulation by long noncoding RNAs[J]. Annu Rev Biochem, 2012,81:145-66. DOI: 10.1146/annurev-biochem-051410-092902.
[26] Ao YQ, Gao J, Jiang JH, et al. Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village[J]. Mol Ther, 2023, 31(12):3389-3413. DOI: 10.1016/j.ymthe.2023.09.015.
[27] Huarte M. The emerging role of lncRNAs in cancer[J]. Nat Med, 2015, 21(11): 1253-1261. DOI: 10.1038/nm.3981.
[28] Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways [J]. Cancer Cell, 2016, 29(4): 452-463. DOI: 10.1016/j.ccell.2016.03.010.
[29] Bhan A, Mandal SS. Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease[J]. ChemMedChem, 2014, 9(9):1932-1956. DOI: 10.1002/cmdc.201300534.
[30] Chen Z, Tang W, Ye W, et al. ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer[J]. Cell Cycle, 2022, 21(16): 1710-1725. DOI: 10.1080/15384101.2022.2067675.
[31] Wu J, Liu Y, Huang X, et al. LncRNA DGCR5 silencing enhances the radio-sensitivity of human esophageal squamous cell carcinoma via negatively regulating the warburg effect[J]. Radiat Res, 2023, 199(3): 264-272. DOI: 10.1667/RADE-22-00126.1.
[32] Liu JQ, Deng M, Xue NN, et al. lncRNA KLF3-AS1 suppresses cell migration and invasion in ESCC by impairing miR-185-5p-targeted KLF3 inhibition [J]. Mol Ther Nucleic Acids, 2020, 20: 231-241. DOI: 10.1016/j.omtn.2020.01.020.
[33] Chen L, Lu J, Li X, et al. LncRNA KTN1-AS1 facilitates esophageal squamous cell carcinoma progression via miR-885-5p/STRN3 axis[J]. Genes Genomics, 2024, 46(2): 241-252. DOI: 10.1007/s13258-023-01451-0.
[34] Zhong YB, Shan AJ, Lv W, et al. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma[J]. Eur Rev Med Pharmacol Sci, 2018, 22(23): 8288-8297. DOI: 10.26355/eurrev_201812_16526.
[35] Li P, Ding H, Han S, et al. Long noncoding RNA LINC00858 aggravates the progression of esophageal squamous cell carcinoma via regulating the miR-425-5p/ABL2 axis[J]. Heliyon, 2024,10(6): e27337. DOI: 10.1016/j.heliyon.2024.e27337.
[36] Hu D, Ma A, Lu H, et al. LINC00963 promotes cisplatin resistance in esophageal squamous cell carcinoma by interacting with miR-10a to upregulate SKA1 expression[J]. Appl Biochem Biotechnol, 2024, 196(10):7219-7232. DOI: 10.1007/s12010-024-04897-4.
[37] Zhao F, Tian H, Wang Y, et al. LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma[J]. Cancer Immunol Immunother, 2023, 72(6):1835-1851. DOI: 10.1007/s00262-022-03364-5.
[38] Liang F, Luo Q, Han H, et al. Long noncoding RNA LINC01088 inhibits esophageal squamous cell carcinoma progression by targeting the NPM1-HDM2-p53 axis[J]. Acta Biochim Biophys Sin (Shanghai), 2023, 55(3):367-381. DOI: 10.3724/abbs.2023021.
[39] Zhang Y, Miao Y, Shang M, et al. LincRNA-p21 leads to G1 arrest by p53 pathway in esophageal squamous cell carcinoma[J]. Cancer Manag Res, 2019,11:6201-14. DOI: 10.2147/cmar.S197557.
[40] Xiao Y, Tang J, Yang D, et al. Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis[J]. Biomark Res, 2022, 10(1):60. DOI: 10.1186/s40364-022-00408-x.
[41] Cheng W, Shi X, Lin M, et al. LncRNA MAGI2-AS3 overexpression sensitizes esophageal cancer cells to irradiation through down-regulation of HOXB7 via EZH2[J]. Front Cell Dev Biol, 2020, 8:552822. DOI: 10.3389/fcell.2020.552822.
[42] Zhang S, Zhong J, Guo D, et al. MIAT shuttled by tumor-secreted exosomes promotes paclitaxel resistance in esophageal cancer cells by activating the TAF1/SREBF1 axis[J]. J Biochem Mol Toxicol, 2023, 37(8): e23380. DOI: 10.1002/jbt.23380.
[43] Chu J, Li H, Xing Y, et al. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis[J]. Biomed Pharmacother, 2019, 116: 109029. DOI: 10.1016/j.biopha.2019.109029.
[44] Wang Y, Wang Y, Zhang J, et al. LncRNA NONHSAT227443.1 confers esophageal squamous cell carcinoma chemotherapy resistance by activating PI3K/AKT signaling via targeting MRTFB[J]. Technol Cancer Res Treat, 2024, 23: 15330338241274369. DOI: 10.1177/15330338241274369.
[45] Xu T, Yan Z, Lu J, et al. Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK1[J]. Clin Exp Metastasis, 2022, 39(5): 757-769. DOI: 10.1007/s10585-022-10174-7.
[46] Huang L, Wang Y, Chen J, et al. Long noncoding RNA PCAT1, a novel serum-based biomarker, enhances cell growth by sponging miR-326 in oesophageal squamous cell carcinoma [J]. Cell Death Dis, 2019, 10(7): 513. DOI: 10.1038/s41419-019-1745-4.
[47] Huang T, You Q, Huang D, et al. A positive feedback between PDIA3P1 and OCT4 promotes the cancer stem cell properties of esophageal squamous cell carcinoma[J]. Cell Commun Signal, 2024, 22(1): 60. DOI: 10.1186/s12964-024-01475-3.
[48] Yao GL, Pan CF, Xu H, et al. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma[J]. Biomed Pharmacother, 2017, 88: 778-785. DOI: 10.1016/j.biopha.2017.01.124.
[49] Xu LJ, Yu XJ, Wei B, et al. LncRNA SNHG7 promotes the proliferation of esophageal cancer cells and inhibits its apoptosis [J]. Eur Rev Med Pharmacol Sci, 2018, 22(9): 2653-2661. DOI: 10.26355/eurrev_201805_14961.
[50] Chang ZW, Jia YX, Zhang WJ, et al. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1[J]. J Exp Clin Cancer Res, 2018, 37(1): 56. DOI: 10.1186/s13046-018-0724-4.
[51] Guo B, He M, Ma M, et al. Long non-coding RNA X-inactive specific transcript promotes esophageal squamous cell carcinoma progression via the microRNA 34a/Zinc finger E-box-binding homeobox 1 pathway[J]. Dig Dis Sci, 2024, 69(4):1169-1181. DOI: 10.1007/s10620-024-08269-0.
[52] Sahebi R, Malakootian M, Balalaee B, et al. Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma[J]. Iran J Basic Med Sci, 2016, 19(10): 1131-1135.
[53] Wang Z, Liu XC, Gao ZG, et al. FOXD2-AS1 is modulated by METTL3 with the assistance of YTHDF1 to affect proliferation and apoptosis in esophageal cancer[J]. Acta Pharm, 2025, 75(1): 69-86. DOI: 10.2478/acph-2025-0009.
[54] Wang Z, Li K, Zhang X, et al. LINC00942 accelerates esophageal cancer progression by raising PRKDC through interaction with PTBP1[J]. J Biochem Mol Toxicol, 2025, 39(3): e70220. DOI: 10.1002/jbt.70220.
[55] Xue Y, Yang R, Gong P, et al. lncRNA FENDRR predicts adverse prognosis and regulates the development of esophageal squamous cell carcinoma through negatively modulating miR-495-3p[J]. Turk J Gastroenterol, 2025, 20. DOI: 10.5152/tjg.2025.24350.
[56] Tang Z, Jiang Y, Zong Y, et al. LncRNA SSTR5-AS1 promotes esophageal carcinoma through regulating ITGB6/JAK1/STAT3 signaling[J]. Epigenomics, 2024,16(17):1133-1148. DOI: 10.1080/17501911.2024.2388018.
[57] Shi X, Zhang X, Huang X, et al. N6-methyladenosine-mediated upregulation of LNCAROD confers radioresistance in esophageal squamous cell carcinoma through stabilizing PARP1[J]. Clin Transl Med, 2024, 14(10):e70039. DOI: 10.1002/ctm2.70039.
[58] Wu K, Wang Z, Huang Y, et al. LncRNA PTPRG-AS1 facilitates glycolysis and stemness properties of esophageal squamous cell carcinoma cells through miR-599/PDK1 axis[J]. J Gastroenterol Hepatol, 2022, 37(3):507-517. DOI: 10.1111/jgh.15719.
[59] 赵舒雅,李航,樊赛军. LncRNA调控肿瘤细胞辐射敏感性作用的研究进展[J]. 国际放射医学核医学杂志,2021,45(11):701-709. DOI:10.3760/cma.j.cn121381-202101027-00116.
[60] Kirkeby A, Main H, Carpenter M. Pluripotent stem-cell-derived therapies in clinical trial: a 2025 update[J]. Cell Stem Cell, 2025, 32(1):10-37. DOI: 10.1016/j.stem.2024.12.005.
[61] 吴漫,刘亚萍. 长链非编码RNA在调控EMT及肿瘤侵袭转移中的作用[J]. 中国细胞生物学学报,2023,45(3):405-411. DOI:10.11844/cjcb.2023.03.0007.